BPR Medical has received Medical Device Single Audit Program (MDSAP) certification for its medical gas solutions.

The UK-based company said the recognition highlights its medical gas therapy products across hospital, home and hospice care.

An auditing standard for Quality Management Systems (QMS), MDSAP allows medical device manufacturers to undergo a single audit for compliance with ISO 13485 and the relevant requirements of US, Canada, Brazil, Australia, and Japan.

Commenting on the recognition, Richard Radford, Managing Director at BPR Medical, said, “We have always strived to create the highest quality products, with every device we produce undergoing stringent tests at every stage of the production process.”

“We are honoured to receive this recognition of our commitment to quality and regulatory requirements, and this now means we can continue making respiratory therapy safer for patients across the globe.”

BPR Medical already provides gas therapy products to the NHS and UK and global healthcare providers, but the new certification will enable the company to continue further expansion across the five markets covered by the accreditation.

The certificate award comes after the medical gas control specialist received a minimal number of Corrective Action Requests (CARs) during the audit process, below average for MDSAP.